FDA Drug Application (020303) for PREMPHASE (PREMARIN;CYCRIN 14/14) by WYETH PHARMS INC

Back to FDA Applications sponsored by WYETH PHARMS INC

Application Number020303
Product Number002
FormTABLET;ORAL-28
Dosage0.625MG;N/A,5MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePREMPHASE (PREMARIN;CYCRIN 14/14)
Active IngredientESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE

Active IngredientCount
List of drugs with Active Ingredient ESTROGENS, CONJUGATED10
List of drugs with Active Ingredient MEDROXYPROGESTERONE ACETATE12


Back to FDA Applications sponsored by WYETH PHARMS INC